A peptide antagonist derived from platelet-derived growth factor induces histamine release from rat peritoneal mast cells

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 1, 1997, Pages 79-81

  Fujii, Toshihiro ^a   Yokoyama, Hiroyuki ^a   Li, Guo Feng ^a   Tada, Hiroiku ^a  

^a SHINSHU UNIVERSITY   (Japan)

Author keywords

actin; calmodulin inhibitor; histamine release; kinase inhibitor; mast cell; platelet derived growth factor antagonist

Indexed keywords

ACTIN; CALCIMYCIN; CALCIUM ION; CALMIDAZOLIUM; CALMODULIN INHIBITOR; CHLORPROMAZINE; COMPOUND 48-80; GENISTEIN; HISTAMINE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; RECEPTOR BLOCKING AGENT; STAUROSPORINE; SYNTHETIC PEPTIDE; TRIFLUOPERAZINE; TUBULIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EXOCYTOSIS; HISTAMINE RELEASE; IMMUNOBLOTTING; MALE; NONHUMAN; PERITONEUM MAST CELL; RAT; SIGNAL TRANSDUCTION;

EID: 0031013129     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.79     Document Type: Article

References (22)

1. Ishizaka T., Ishizaka K., Prog. Allergy, 34, 188-235 (1984).
2. Metzger H., Alcaras G., Hohman R. J., Kinet J.-P., Pribluda V., Quarto R., Annu. Rev. Immunol., 4, 419-470 (1986).
3. Jasani B., Kreil G., Mackler B. F., Stanworth D. R., Biochem. J., 181, 623-632 (1979).
4. Argiolas A., Pisano J. J., J. Biol. Chem., 260, 1437-1444 (1985).
5. Heldin C.-H., Westermark B., Cell Regul., 1, 555-566 (1990).
6. Meyer-Ingold W., Eichner W., Cell Biol. Int., 19, 389-398 (1995).
7. Engstrom U., Engstrom A., Ernlund A., Westermark B., Heldin C.-H., J. Biol. Chem., 267, 16581-16587 (1992).
8. Kreysing J., Ostman A., van de Poll M., Backstrom G., Heldin C.-H., FEBS Lett., 385, 181-184 (1996).
9. Antoniades H. N., Scher C. D., Stiles C. D., Proc. Natl. Acad. Sci U.S.A., 76, 1809-1813 (1979).
10. Fujii T., Kuzumaki N., Ogoma Y., Kondo Y., Biol. Pharm. Bull., 17, 581-585 (1994).
11. Shore P. A., Burkhalter A., Cohn V. H., Jr., J. Pharmacol. Exp. Ther., 127, 182-186 (1959).
12. Laemmli U. K., Nature (London), 227, 680-685 (1970).
13. Fujii T., Imai M., Rosenfeld G. C., Bryan J., J. Biol. Chem., 262, 2757-2763 (1987).
14. Chakravarty N., Agents Actions, 30, 5-12 (1990).
15. Izushi K., Tasaka K., Pharmacology, 44, 61-70 (1992).
16. Razin E., Szallasi Z., Kazanietz M. G., Blumberg P. M., Rivera J., Proc. Natl. Acad. Sci. U.S.A., 91, 7722-7726 (1994).
17. Chakravarty N., Nielsen E. H., Agents Actions, 16, 122-125 (1985).
18. Douglas W. W., Nemeth E. F., J. Physiol., 323, 229-244 (1982).
19. Izushi K., Tasaka K., Immunopharmacol., 18, 177-186 (1989).
20. Kinashi T., Escobedo J. A., Williams L. T., Takatsu K., Springer A., Blood, 86, 2086-2090 (1995).
21. Tasaka K., Mio M., Fujisawa K., Aoki I., Biochem. Pharmacol., 41, 1031-1037 (1991).
22. Koffer A., Tatham P. E. R., Gomperts B. D., J. Cell Biol., 111, 919-927 (1990).